Aug 2026· Frontiers in Psychiatry· Vol 17· 0 citations· 77 references
Medicine
TL;DR
This review synthesizes current findings on the interplay among dietary patterns, gut microbiota dysbiosis, intestinal barrier dysfunction, and neuroimmune activation in ASD and evaluates microbiota-targeted interventions, including probiotics and fecal microbiota transplantation, as potential therapeutic strategies.
Abstract
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by social deficits and repetitive behaviors, often accompanied by gastrointestinal (GI) symptoms such as constipation, diarrhea, and abdominal pain. Emerging evidence highlights the gut-brain axis as a key pathway linking GI dysfunction to ASD pathophysiology. This review synthesizes current findings on the interplay among dietary patterns, gut microbiota dysbiosis, intestinal barrier dysfunction, and neuroimmune activation in ASD. We also discuss shared genetic vulnerabilities and environmental factors influencing both gut and brain function. Finally, we evaluate microbiota-targeted interventions, including probiotics and fecal microbiota transplantation, as potential therapeutic strategies. Understanding these mechanisms may inform personalized approaches to managing GI and behavioral symptoms in ASD.
The interaction between gut microbiota and neuroinflammation in ASD is reviewed to provide insights for treatment and research, aiming to provide insights for treatment and research.
Cong Hu, He-Li Li, Yun-Jie Li et al.· Current Neuropharmacology· 0 citations
Intervention strategies targeting the gut microbiota-such as probiotics/prebiotics supplementation, fecal microbiota transplantation (FMT), and gluten-free/casein-free diets-show promise in alleviating gastrointestinal symptoms and core behavioral deficits in children with ASD.
Song-Qiu Qin, Yuan Lin, Yi-Meng Chen et al.· Frontiers in Microbiology· 1 citation
This review summarizes current evidence on alterations in the gut microbiota in ASD and critically examines whether these changes contribute to disease pathogenesis or represent secondary effects, and highlights recent advances in multi-kingdom microbiome profiling, metabolomics, mechanistic studies of neuro inflammati...
Ahmed Kabrah, Saad Alghamdi, Anmar A. Khan et al.· Journal of Disability Resear...· 0 citations
The authors analyze GBA dysfunction across major DGBIs subtypes (irritable bowel syndrome, functional dyspepsia, and functional abdominal pain syndrome), highlighting microbiota dysbiosis, barrier dysfunction, and central sensitization.
Cong Yu, Xiu-Juan Wang, Shu-Zhu Chen· The Turkish Journal of Gastr...· 0 citations
A narrative review that summarizes the current research progress regarding the association between vitamin D deficiency and gut microbiota dysbiosis in ASD and suggests future studies should focus on dissecting the underlying molecular crosstalk and developing personalized intervention strategies targeting vitamin D st...
Gui-Mei Peng, Fa-Long Li, Yu-Hua Su et al.· International Journal of Gen...· 0 citations
Inflammatory bowel disease (IBD) is a chronic immune-mediated disorder of the gastrointestinal tract that is frequently associated with neuropsychiatric comorbidities, such as anxiety, depression, and other neurological disorders. Accumulating evidence suggests that these neuropsychiatric disorders are secondary condit...
Bing-Chan Sun, Guo-Xin Wang, Xiao-Xiao Li et al.· Journal of Neurogastroentero...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.